Codeine Phosphate (Douglas) Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

codeine phosphate (douglas)

douglas pharmaceuticals limited - codeine phosphate hemihydrate 60mg;   - tablet - 60 mg - active: codeine phosphate hemihydrate 60mg   excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b povidone purified water   sodium starch glycolate

Solpadeine Migraine Ibuprofen & Codeine Tablets Мальта - англійська - Medicines Authority

solpadeine migraine ibuprofen & codeine tablets

omega pharma limited 1st floor, 32 vauxhall bridge road, london sw1v 2sa, united kingdom - codeine phosphate, hemihydrate, ibuprofen - film-coated tablet - codeine phosphate hemihydrate 12.8 mg ibuprofen 200 mg - antiinflammatory and antirheumatic products

ACETAMINOPHEN AND CODEINE- acetaminophen and codeine phosphate tablet США - англійська - NLM (National Library of Medicine)

acetaminophen and codeine- acetaminophen and codeine phosphate tablet

par pharmaceutical, inc. - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - codeine phosphate 30 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia, have not provided adequate analgesia, or are not expected to provide adequate analgesia, - have not been tolerated, or are not expected to be tolerated. have not been tolerated, or are not expected to be tolerated. acetaminophen and codeine phosphate tablets are contraindicated for: • all children younger than 12 years of age [see warnings ]. • post-operative management in children younger than 18 years of age following tonsillectomy and/or aden

PARACODE EXTRA paracetamol 500 mg and codeine phosphate hemihydrate 15 mg tablet blister pack Австралія - англійська - Department of Health (Therapeutic Goods Administration)

paracode extra paracetamol 500 mg and codeine phosphate hemihydrate 15 mg tablet blister pack

neo health (otc) pty ltd - codeine phosphate hemihydrate, quantity: 15 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: methylcellulose; purified talc; calcium stearate; maize starch; povidone - for the temporary relief of acute moderate pain in patients over the age of 18 years

CODPHOS codeine phosphate hemihydrate 30 mg tablet blister pack Австралія - англійська - Department of Health (Therapeutic Goods Administration)

codphos codeine phosphate hemihydrate 30 mg tablet blister pack

aspen pharmacare australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate - codphos tablets are indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

NEODOL FORTE 500 / 30 paracetamol / codeine phosphate hemihydrate 500mg / 30mg tablets blister pack Австралія - англійська - Department of Health (Therapeutic Goods Administration)

neodol forte 500 / 30 paracetamol / codeine phosphate hemihydrate 500mg / 30mg tablets blister pack

arrotex pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet - excipient ingredients: povidone; stearic acid; magnesium stearate; pregelatinised maize starch - short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

PARAMAX FORTE 500 / 30 paracetamol / codeine phosphate hemihydrate 500mg / 30mg tablets blister pack Австралія - англійська - Department of Health (Therapeutic Goods Administration)

paramax forte 500 / 30 paracetamol / codeine phosphate hemihydrate 500mg / 30mg tablets blister pack

arrotex pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet - excipient ingredients: magnesium stearate; stearic acid; povidone; pregelatinised maize starch - short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

COPARADEINE FORTE 500 / 30 paracetamol / codeine phosphate hemihydrate 500mg / 30mg tablets blister pack Австралія - англійська - Department of Health (Therapeutic Goods Administration)

coparadeine forte 500 / 30 paracetamol / codeine phosphate hemihydrate 500mg / 30mg tablets blister pack

arrotex pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet - excipient ingredients: pregelatinised maize starch; magnesium stearate; stearic acid; povidone - short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

SANDOZ PARACETAMOL PLUS CODEINE paracetamol 500mg and codeine phosphate hemihydrate 15mg tablets blister pack Австралія - англійська - Department of Health (Therapeutic Goods Administration)

sandoz paracetamol plus codeine paracetamol 500mg and codeine phosphate hemihydrate 15mg tablets blister pack

sandoz pty ltd - codeine phosphate hemihydrate, quantity: 15 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; povidone; lactose monohydrate; docusate sodium; potato starch; magnesium stearate; ethanol; purified water - for the temporary relief of acute moderate pain in patients over the age of 12 years (see also contraindications and paediatric use)